total white cell count or total polymorphonuclear cell count over the same period. In contrast there was no change in the total lymphocyte count in an age and sex matched group of RA patients treated with penicillamine. This previously unreported observation may give new insight into the mechanism of action of gold salts in RA.
Lymphocytes are thought to play an important part in the pathogenesis of rheumatoid arthritis (RA), being present in large numbers in rheumatoid synovial membrane and synovial fluid. In Joint erosions on plain x-rays of hands and feet were present in eight patients. All were taking various non-steroidal anti-inflammatory drugs, but none had previously been treated with remittive antirheumatic agents.
Patients were assessed before and, when possible, after receiving 250, 500, and 1000 mg of sodium aurothiomalate, which was given in weekly increments of 50 mg by intramuscular injection. During treatment every effort was made to maintain the patients' analgesic and anti-inflammatory medications at a constant level. Shortly after beginning sodium aurothiomalate three patients received a short course of oral prednisolone, which was tapered as rapidly as possible and discontinued in all cases at least one month prior to their final assessments. Disease activity was measured by standard clinical and laboratory indices, including the duration of morning stiffness, Ritchie articular score, pain expressed on a 100 mm visual analogue scale, grip strength, peripheral blood haemoglobin level, and erythrocyte sedimentation rate (ESR) (Westergren). From these parameters an index of disease activity (IDA) with a range of 1-4 was derived by multivariate analysis.8 The higher the IDA, the greater the disease activity.
At each assessment the absolute number of PB lymphocytes was determined from the full blood count and the differential count. The latter was performed by an independent assessor, who was unaware of the patients' therapy or disease status. In addition the changes in PB lymphocyte counts in 10 age and sex matched RA patients, after beginning D-penicillamine (DP), were examined retrospectively. The initial dose of DP was 250 mg daily, which was increased gradually over the ensuing four months to a maintenance dose of 500 mg daily. The follow up period for both groups of patients was similar.
Results were analysed by the Wilcoxon signed rank test and the Spearman rank correlation test.
Results
The changes in disease activity and absolute numbers of lymphocytes after the start of sodium aurothiomalate are shown in Fig. 1 109/l)).
In contrast to the changes in PB lymphocytes with sodium aurothiomalate there was no change in the number of circulating lymphocytes in those patients receiving DP (mean±SEM: 1779±170 v 1713±171/ mm3 (1-779±0.17x109 v 1.713±0.171x109/1) ).
Discussion
The results suggest that sodium aurothiomalate induces a consistent reduction in the number of PB lymphocytes while modifying disease activity in RA patients. This reduction occurred shortly after beginning gold treatment and was maintained throughout the study period. In contrast no such change was seen in an age and sex matched group of RA patients receiving DP. This important observation has not been recorded previously.
Lymphocytes are fundamentally involved in rheumatoid inflammation, and abnormalities have been found in both the numbers9 l" and functions11 12 of various subpopulations of lymphocytes. 
